Descriptive analysis of the epidemiological, clinical and laboratory profile of patients at the spondyloarthritis outpatient clinic of a university hospital
DOI:
https://doi.org/10.47456/rbps.v26i1.51120Keywords:
Ankylosing Spondylitis, Psoriatic Arthritis, Clinical EpidemiologyAbstract
Introduction: The term Spondyloarthritis (SpA) is used to describe a group of diseases with common clinical, laboratory and genetic characteristics, which may involve the axial and/or peripheral skeleton. Objectives: To study the epidemiological profile, the current clinical status of the patients and the drugs most commonly used to control the disease. Methods: Cross-sectional study of patients who were regularly followed up at the Cassiano Antônio de Moraes University Hospital (HUCAM-UFES), one of the centers participating in the prospective and observational cohort of the Brazilian Spondyloarthritis Registry (RBE). Additional data was obtained from the patients’ electronic medical records. Results: 105 patients were studied; there was a predominance of brown individuals 52 (49.5%), men (64/61%) and the average age was 49 years; with a higher prevalence of ankylosing spondylitis (62/59%), axial form (76/72.4%), with HLA-B27 positivity in 55 (52.4%) individuals. We identified 50 (47.6%) patients with csDMARDs and 87 (82.9%) with bDMARDs, with a mean ASDAS-PCR: 3.3 (± 1.8), BASDAI: 3.6 (± 2.5) and DAPSA: 21.5 (± 21.8). White color was associated with greater positivity for HLA-B27 and black color with greater disease activity by ASDAS-PCR. Conclusion: In this study, there was a predominance of men of African descent and greater axial involvement. HLA-B27 was identified as an important genetic marker associated with the patients’ phenotype. Black patients had higher activity rates compared to the other groups. Treatment with bDMARDs was predominant, with patients in disease activity, demonstrating a sample with a profile of greater severity and difficult treatment.
Downloads
References
Marques CDL, Gonçalves CR, Saad CGS, Pinheiro MM, Oliveira TLO. Espondiloartrites axiais. In: Moreira C, Shinjo SK, Pereira IA, Ugolini-Lopes M, Hax V. Livro da Sociedade Brasileira de Reumatologia, 3°ed, São Paulo-SP, Manole; 2023, p:325-40.
Fattorini F, Gentileschi S, Cigolini C, Terenzi R, Pata AP, Esti L, et al. Axial spondyloarthritis: one year in review 2023. Clin Exp Rheumatol. 2023;41(11):2142–50.
Rudwaleit M, Landewe R, van der Heijde D, Listing J, Brandt J, Braun J, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal. Ann Rheum Dis. 2009;68(6):770–6.
Rudwaleit M, van der Heijde D, Landewé R, Listing J, Akkoc N, Brandt J, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis. 2009;68(6):777–83
Rudwaleit M, van der Heijde D, Landewe R, Akkoc N, Brandt J, Chou CT, et al. The Assessment of SpondyloArthritis international Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis. 2010;70(1):25–31.
Resende GG, Saad CGS, Marques CDL, Ribeiro SLE, de Oliveira Gavi MBR, Yazbek MA, et al. To be or not to B27 positive: implications for the phenotypes of axial spondyloarthritis outcomes. Data from a large multiracial cohort from the Brazilian Registry of Spondyloarthritis. Adv Rheumatol. 2024;64(1):33.
Stolwijk C, Boonen A, van Tubergen A, Reveille JD. Epidemiology of spondyloarthritis. Rheum Dis Clin North Am. 2012;38(3):441–76.
Sampaio-Barros PD. Epidemiology of spondyloarthritis in Brazil. Am J Med Sci. 2011;341(4):287–8.
Gallinaro AL, Ventura C, Sampaio Barros PD, Gonçalves CR. Spondyloarthritis: analysis of a Brazilian series compared with a large Ibero-American registry (RESPONDIA group). Rev Bras Reumatol. 2010; 50(5):581–9.
Baima JP, Imbrizi M. Second Brazilian consensus on the management of ulcerative colitis in adults: a consensus of the Brazilian Organization for Crohn’s Disease and Colitis (GEDIIB). Arq Gastroenterol. 2022;59(Suppl 1):20–50.
Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H, et al. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum. 2006;54(8):2665–73.
Wang R, Ward MM. Epidemiology of axial spondyloarthritis: an update. Curr Opin Rheumatol. 2018;30(2):137–43.
da Costa IP, Bortoluzzo AB, Gonçalves CR, da Silva JAB, Ximenes AC, Bértolo MB, et al. Avaliação do desempenho do BASDAI (Bath Ankylosing Spondylitis Disease Activity Index) numa coorte brasileira de 1.492 pacientes com espondiloartrites: dados do Registro Brasileiro de Espondiloartrites (RBE). Rev Bras Reumatol. 2015;55(1):48–54.
Dey M, Nikiphorou E. Navigating the landscape in axial spondyloarthritis: unravelling regional phenotypic differences. Rheumatology (Oxford). 2024;63(9):2321–2.
Poddubnyy D, Sommerfleck F, Navarro-Compán V, Bundy C, Makri S, Akerkar S, et al. Regional differences in clinical phenotype of axial spondyloarthritis: results from the International Map of Axial Spondyloarthritis (IMAS). Rheumatology (Oxford). 2024;63(9):2328–35.
Tayel MY, Soliman E, El Baz WF, El Labaan A, Hamaad Y, Ahmed MH. Registry of the clinical characteristics of spondyloarthritis in a cohort of Egyptian population. Rheumatol Int. 2012;32(9):2837–42.
Redeker I, Callhoff J, Hoffmann F, Marschall U, Haibel H, Sieper J, et al. The prevalence and impact of comorbidities on patients with axial spondyloarthritis: results from a nationwide population-based study. Arthritis Res Ther. 2020;22(1):210.
Zhao SS, Robertson S, Reich T, Harrison NL, Moots RJ, Goodson NJ. Prevalence and impact of comorbidities in axial spondyloarthritis: systematic review and meta-analysis. Rheumatology (Oxford). 2020;59(Suppl4):iv47–57.
Zhao SS, Radner H, Siebert S, Duffield SJ, Thong D, Hughes DM, et al. Comorbidity burden in axial spondyloarthritis: a cluster analysis. Rheumatology (Oxford). 2019;58(10):1746–54.
Hintenberger R, Affenzeller B, Vladychuk V, Pieringer H. Cardiovascular risk in axial spondyloarthritis-a systematic review. Clin Rheumatol. 2023;42(10):2621–33.
Wiąk-Walerowicz KM, Wielosz E. Comparison of Ankylosing Spondylitis Disease Activity Score and Bath Ankylosing Spondylitis Disease Activity Index tools in assessment of axial spondyloarthritis activity. Rheumatology. 2024 Mar 18 [cited 2024 Sep 21];62(1):64–9.
Michielsens C, Bolhuis TE, van Gaalen FA, van den Hoogen F, Verhoef LM, den Broeder N, et al. Construct validity of Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and Ankylosing Spondylitis Disease Activity Score (ASDAS) treatment target cut-offs in a BASDAI treat-to-target axial spondyloarthritis cohort: a cross-sectional study. Scand J Rheumatol. 2024;53(3):180–7.
Ramiro S, Nikiphorou E, Sepriano A, Ortolan A, Webers C, Baraliakos X, et al. ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update. Ann Rheum Dis. 2023;82(1):19–34.
Di Giuseppe D, Lindström U, Aaltonen K, Relas H, Provan S, Gudbjornsson B, et al. The occurrence of multiple treatment switches in axial spondyloarthritis. Results from five Nordic rheumatology registries. Rheumatology (Oxford). 2022;61(9):3647–56.
Jamalyaria F, Ward MM, Assassi S, Learch TJ, Lee M, Gensler LS, et al. Ethnicity and disease severity in ankylosing spondylitis a cross-sectional analysis of three ethnic groups. Clin Rheumatol . 2017;36(10):2359–64.
Skare TL, Bortoluzzo AB, Gonçalves CR, Braga da Silva JA, Ximenes AC, Bértolo MB, et al. Ethnic influence in clinical and functional measures of Brazilian patients with spondyloarthritis. J Rheumatol [Internet]. 2012;39(1):141–7.
Philippoteaux C, Delepine T, Cailliau E, Philippe P, Taisne N, Pascart T, et al. Characteristics of difficult-to-treat axial spondyloarthritis: Results of a real-world multicentric study. Joint Bone Spine. 2024;91(2):105670.
Fakih O, Desmarets M, Martin B, Prati C, Monnet E, Verhoeven F, et al. Difficult-to-treat axial spondyloarthritis is associated with psoriasis, peripheral involvement and comorbidities: results of an observational nationwide study. RMD Open. 2023;9(4).
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Brazilian Journal of Health Research
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors and reviewers must disclose any financial, professional, or personal conflicts of interest that could influence the results or interpretations of the work. This information will be treated confidentially and disclosed only as necessary to ensure transparency and impartiality in the publication process.
Copyright
RBPS adheres to the CC-BY-NC 4.0 license, meaning authors retain copyright of their work submitted to the journal.
- Originality Declaration: Authors must declare that their submission is original, has not been previously published, and is not under review elsewhere.
- Publication Rights: Upon submission, authors grant RBPS the exclusive right of first publication, subject to peer review.
- Additional Agreements: Authors may enter into non-exclusive agreements for the distribution of the RBPS-published version (e.g., in institutional repositories or as book chapters), provided the original authorship and publication by RBPS are acknowledged.
Authors are encouraged to share their work online (e.g., institutional repositories or personal websites) after initial publication in RBPS, with appropriate citation of authorship and original publication.
Under the CC-BY-NC 4.0 license, readers have the rights to:
- Share: Copy and redistribute the material in any medium or format.
- Adapt: Remix, transform, and build upon the material.
These rights cannot be revoked, provided the following terms are met:
- Attribution: Proper credit must be given, a link to the license provided, and any changes clearly indicated.
- Non-Commercial: The material cannot be used for commercial purposes.
- No Additional Restrictions: No legal or technological measures may be applied to restrict others from doing anything the license permits.
